Primary cultures of Sertoli cells provide an interesting model to study how signalling pathways induced by a single hormone in a single cell type evolve, depending on the developmental stage. In vivo, follicle-stimulating hormone (FSH) induces proliferation of Sertoli cells in neonate and controls the subsequent dierentiation of the entire population. Molecular mechanisms underlying Sertoli cell pleiotropic responses to FSH have long been investigated. But to date, only cAMP-dependent kinase (PKA) activation has been reported to account for most FSH biological activities in male. Here, we demonstrate that FSH activates the ERK MAP kinase pathway following dual coupling of the FSH-R both to Gs and to Gi heterotrimeric proteins, in a PKA-and also Srcdependent manner. This activation is required for FSHinduced proliferation of Sertoli cells isolated 5 days after birth. Consistently, we show that the ERK-mediated FSH mitogenic eect triggers upregulation of cyclin D1. In sharp contrast, at 19 days after birth, as cells proceed through their dierentiation program, the ERK pathway is dramatically inhibited by FSH treatment. Taken together, these results show that FSH can exert opposite eects on the ERK signalling cascade during the maturation process of Sertoli cells. Thus, signalling modules triggered by the FSH-R evolve dynamically throughout development of FSH natural target cells. Oncogene (2001) 20, 4696 ± 4709.
Introduction
Stimulation of cell-surface G protein-coupled receptors (GPCRs) elicits biological responses to a plethora of extracellular signals such as hormones and neurotransmitters. Ligand-bound GPCRs stimulate biochemical pathways initiated by the recruitment and activation of Ga and Gbg proteins, and subsequent release of intracellular second messengers such as cAMP. Over the last decade, it has become increasingly clear that GPCRs can also profoundly aect cell growth and dierentiation processes by interfering with the mitogen-activated protein kinase (MAP kinase) cascades. MAP kinase-dependent pathways group a set of signalling modules (reviewed in van Biesen et al., 1996) , including membrane recruitment by a small G protein of the Ras type of a Ser/Thr kinase of the Raf family (MAP kinase kinase kinase) which subsequently activates a Thr-and Tyr dual speci®city kinase (MAP kinase kinase) such as MEK1 or MEK2 (reviewed in Tan and Kim, 1999) .
The outcomes of cAMP and PKA modulation on MAP kinase activity, which re¯ect tissue-speci®city of the signalling modules recruited, are expected to ultimately elicit dierent biological responses. cAMP has long been viewed as an inhibitory signal towards mitogenic stimuli by antagonizing the MAP kinase pathway, as illustrated by Rat-1 ®broblast response to EGF (Wu et al., 1993) and to LPA (Cook and McCormick, 1993) . Conversely, ERK activation by cAMP and/or PKA has mainly been evidenced by rare examples of transformed cell lines such as cAMPtreated Jurkat cells (Saxena et al., 1999) , PC12 neuronal cells (Vossler et al., 1997) , a-MSH-stimulated B16 melanoma cells (Busca et al., 2000) , and isoproterenol-stimulated HEK293 cells . These cell models have certainly broadened our current knowledge of signalling mechanisms. Notwithstanding, they are proven poorly helpful when a physiological issue is addressed. Physiological antagonism of MAP kinase and PKA signalling was ®rst demonstrated in human arterial smooth muscle cells (Graves et al., 1993) in response to PDGF and in adipocytes stimulated by Insulin (Sevetson et al., 1993) . Opposedly, EGF-or isoproterenol-induced proliferation of rat parotid acinar cells via MAP kinase signalling is not impaired by a concomitant cAMP rise (Purushotham et al., 1994) .
Follicle-Stimulating Hormone (FSH) has long been considered as the pituitary key regulator orchestrating gametogenesis. Physiological functions of FSH are mediated by a GPCR and the prevalent signalling pathway induced by FSH has been delineated as follows: ligated FSH-R couples to Gs, and GTP-bound Gas stimulates its major eector, adenylyl cyclase. Subsequent cAMP raise leads to activation of PKA, which targets ATF/CREB-dependent transcriptional events (reviewed in Hansson et al., 2000) . But this sole mechanism does not satisfactorily explain the sequential expression of FSH target genes that likely requires temporal changes in a combinatorial signalling network. Most data which support this notion have been obtained so far in granulosa cells, which are the only FSH target cells in female. Recently, activation of the PKB/Akt kinase pathway by FSH has been reported to occur in terminally dierentiated granulosa cells, in a cAMP-dependent and PKA-independent manner (Gonzalez-Robayna et al., 2000) . In these cells, FSH also activates the p38 (Maizels et al., 1998) and ERK (Cameron et al., 1996; Das et al., 1996) MAP kinases, indicating that the FSH-R owns the structural requirements for coupling to these pathways.
In striking contrast, in male, FSH-mediated signalling has been primarily limited to the cAMP/PKA pathway (Hansson et al., 2000) and to activation of PKC and calcium release in mature male rats (Nikula et al., 1990) . FSH unique target cells in male are Sertoli cells, which coordinate the waves of spermatogenesis by providing germ cells with essential paracrine factors such as TGFb, IGF-1 or EGF (Saez et al., 1991; Spiteri-Grech and Nieschlag, 1993) . FSH stimulates Sertoli cell proliferation during fetal and peri-natal life, until cells establish tight junctions to organize as a blood-testis barrier, which is completed at 19 days in rat (Orth, 1984) .
A major issue to understand FSH physiological function in male is to de®ne the signalling pathways which mediate its proliferative activity, and those which allow the same hormone to guide its target cells towards dierentiation progressively. Here, using primary cultures of rat Sertoli cells, we have investigated whether the ERK pathway could convey FSH response and how this pathway evolves at dierent stages of Sertoli cell maturation.
Results

FSH stimulates the ERK activation pathway in Sertoli cells isolated from neonate rats
Since their original identi®cation, dual phosphorylation on tyrosine and threonine residues has been considered as the hallmark of MAP kinase activation (Cano and Mahadevan, 1995) . In order to examine the ERK activation level following FSH treatment, Sertoli cells were isolated from neonate 5-day-old rats and the phosphorylated, active form of the ERK1 and 2 MAP kinases was immunodetected in whole cell extracts. In response to FSH, a time-dependent ERK1,2 phosphorylation increase was observed ( Figure 1a , lanes 2 ± 5), when compared to unstimulated cell control (lane 1).
The raise in ERK1,2 phosphorylation induced by FSH was weaker than after 10 min EGF stimulation (lane 6). Weaker activation of MAP kinase phosphorylation level, when compared to the response elicited by some tyrosine kinase receptors such as the EGF-R, is a feature commonly shared by GPCRs, as shown for the bombesin or the lysophosphatidic acid receptor among others .
FSH-induced ERK phosphorylation depended on activation of the upstream dual speci®city MAP kinase kinase, namely MEK-1, since it was dramatically inhibited by the MEK-1-speci®c pharmacological inhibitors U0126 (Figure 1b , lanes 4, 5) and PD98059 to a lesser extent (lanes 7, 8) , similarly to the EGF response (lanes 3, 6, 9) . PD98059 utilized at 50 mM provided similar results (not shown). Fifty mM PD98059 and 10 mM U0126 are highly selective at these concentrations for MEK1, as reported recently (Davis et al., 2000) .
Based on their ability to phosphorylate transcription factors of the Ets family (Coer et al., 1994) , FSHinduced ERK kinase activity was con®rmed towards a Ras-responsive element (RRE) composed of three tandem repeats of ETS and AP-1 binding sites ( Figure  1c ). Transient transfection of Sertoli cells with RREdriven luciferase encoding plasmid led to a 1.8-fold RRE activation upon FSH stimulation, when compared with unstimulated control cells. RRE stimulation was due to MEK1-mediated ERK phosphorylation, since the FSH stimulatory eect was abolished by pre-treatment of cells with PD98059. Accordingly, MBP (myelin basic protein) was phosphorylated in vitro by FSH-stimulated cell extracts recovered 5 days post-partum (data not shown). Therefore, FSH has the ability to stimulate a transcriptional response targetted by the MAP kinases. Besides, the Src Tyrosine kinase also contributed to the ERK activation cascade, as shown following pretreatment with the Src-speci®c inhibitor PP2 prior FSH stimulation (Figure 1d , lanes 4, 5), but not prior EGF stimulation (lanes 3, 6).
FSH induces ERK1,2 sustained phosphorylation and nuclear translocation
In most instances, activation of the ERK MAP kinases can trigger their translocation to the nucleus, where they modulate gene expression by phosphorylating transcription factors (Lenormand et al., 1993) . To further substantiate their activation upon FSH stimulation, we examined their sub-cellular tracking. In untreated cells, a negligible amount of FITC-labelled nuclei could be visualized (Figure 2a , left panel, upper part), despite several DAPI-positive nuclei in the ®eld observed (right panel, upper part). In contrast, more than 50% FSH-treated cells exhibited nuclear staining (left panel, lower part), when quanti®ed as a ratio of FITC-labelled-to total DAPI-labelled nuclei (right panel, lower part). This result indicates that FSH stimulation targets a signi®cant portion of the phosphorylated ERK pool to the nucleus.
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Stage-specific regulation of ERK1,2 by FSH P Cre Â pieux et al Figure 1 Eect of FSH on the ERK pathway in primary Sertoli cell isolated 5 days post-partum. (a) Primary Sertoli cells were stimulated with FSH (100 ng/ml) for the indicated periods of time (lanes 2 ± 5), with EGF (100 ng/ml) for 10 min (lane 6), or were left untreated (lane 1). A representative experiment shows basal and agonist-stimulated ERK1,2 phosphorylation (P-ERK), as determined by immunoblotting of the respective whole-cell lysate with an anti-phosphorylated ERK antibody. The membrane was re-probed with a goat anti-ERK1 antibody for normalization. (b) Sertoli cells were pre-incubated for 30 min with U0126 (10 mM) (lanes 4 ± 6) or with PD98059 (100 mM) (lanes 7 ± 9) as indicated, prior to stimulation with FSH for 15 min (lanes 2, 5, 8), with EGF for 10 min (lanes 3, 6, 9), or were left untreated (C) lanes 1, 4, 7). Whole cell extracts were then analysed by immunoblotting probed with an anti-phosphorylated ERK antibody and re-probed with a rabbit anti-ERK1,2 antibody for normalization. (c) Sertoli cells were transfected with a reporter plasmid encoding RRE-driven ®re¯y luciferase. After pre-incubation for 30 min with PD98059 as indicated, cells were either left unstimulated (control) or were stimulated with FSH (100 ng/ml) for 8 h, and then were assayed for ®re¯y luciferase activity. Normalized results are expressed as fold-stimulation of unstimulated cell control, and represent mean values +s.e.m. (d) Sertoli cells were pre-incubated for 30 min with PP2 (5 mM) (lanes 4 ± 6) and then were either stimulated with FSH for 15 min (lanes 2, 5), with EGF for 10 min (lanes 3, 6) or were left untreated (C) lanes 1, 4). Whole cell extracts were then analysed by immunoblotting as in Figure 1a We next examined the duration of the ERK phosphorylation level, considered as a critical parameter in generating a proliferative response (Roovers and Assoian, 2000) . ERK phosphorylation was sustained over 8 h FSH stimulation (Figure 2b ). However, it declined somewhat by 4 h before increasing again after 8 h of stimulation. The reason of this pro®le is unclear, and has also been observed by others in mouse embryonic ®broblasts (Roovers et al., 1999) . This result suggests that FSH induces a biphasic phosphorylation of ERK1,2, which transiently peaks by 15 min stimulation and remains elevated thereafter.
Activation of the ERK pathway mediates FSH proliferative effect
We next investigated whether the ERK pathway could account for FSH-controlled proliferation of Sertoli cells peri-natally. E2F binding sites were used as sensors of Sertoli cell proceeding through the G1/S transition (Brondello et al., 1995) , and S phase nuclei puri®ed from non-synchronized cells were measured by¯ow cytometry. Over long time-course FSH stimulation, both E2F-activity ( Figure 3a ) and the ratio of S phase nuclei (Figure 3b ) increased, when compared with unstimulated cells as estimated at the end of the kinetics. In the subsequent experiments, both parameters were evaluated after 6 and 8 h of stimulation respectively, since these time-points are within the linear phase of the corresponding curves.
After 6 h of FSH stimulation, E2F-driven reporter activity was enhanced by FSH (3.2-fold stimulation) ( Figure 3c ). Pre-treatment with PD98059 abolished activity, thus indicating that FSH-controlled Sertoli cell proliferation depended on MEK-1 activity. Importantly,¯ow cytometry analysis of nuclei indicated that FSH increases the ratio of S phase Sertoli cells isolated shortly after birth (Figure 3d ), in a MEK-1-dependent manner. Considering that FSH induced a MAP kinasedependent proliferative response of Sertoli cells, we hypothesized that some key regulators of progression through the cell cycle could be FSH-responsive genes. From the above mentionned results, FSH could be expected to target early cell cycle regulators which can promote E2F de-repression. Cyclin D1 is the ®rst cyclin to be expressed as the cell passes through mid-G1 and its expression is induced by stimuli that activate MAP kinases (Albanese et al., 1995; Lavoie et al., 1996) . Hence, we sought to determine if cyclin D1 could be an FSH-responsive gene. As shown in Figure 3e , prolonged exposure of Sertoli cells to FSH led to a rapid (2.5-fold after 1 h) increase in cyclin D1 protein level, which levelled o after 4 h, and depended on MEK1 activation. PD98059 treatment also diminished steady-state cyclin D1 level, which is not unexpected since Sertoli cells analysed in this study are not synchronized prior FSH treatment and proliferate autonomously.
FSH-induced ERK activation is mediated by cAMP production and depends on PKA As cAMP plays a key role in mediating FSH biological function, its impact on the ERK activation status was next evaluated. First, it appeared that the adenylyl cyclase activator forskolin (Figure 4 , lane 3) or di(But)-cAMP (lane 4) mimicked FSH-induced ERK phosphorylation. One major eector of cAMP is PKA. When Sertoli cells were pre-treated with the PKA inhibitor H89, both basal and FSH-induced ERK activation was decreased (Figure 4b , lanes 4, 5), indicating that PKA activation is required for proper ERK activation by the hormone as well as for basal ERK phosphorylation. Others reported previously that H89 could interfere with binding of an agonist to its cognate receptor (Penn et al., 1999) . Since cAMP production in H89-treated cell supernatants was found to be increased upon FSH stimulation (data not shown), this possibility can be ruled out. As extensively reported (see Hsueh et al., 1994 for review), the intra-cellular cAMP rise in response to FSH is initially due to Gascoupling of the FSH receptor. Pre-incubation with the Gas antagonist NF449 lowered ERK1,2 phosphorylation ( Figure 4b, lanes 7, 8) , indicating that in Sertoli cells isolated from neonates, the FSH-R couples to Gas to induce cAMP-and PKA-dependent ERK signalling cascade. However, inhibition was partial, suggesting that other coupling(s) may also be involved. Accordingly, pre-incubation of cells with the NF449 inhibitor decreased the amount of cAMP secreted in the extra-cellular medium in response to FSH (data not shown). In contrast, H89 only slightly aected the EGF-stimulated ERK1,2 phosphorylation, while NF449 was ineective. cAMP-dependent ERK1,2 activity was further substantiated by a MEKdependent increase of RRE-driven luciferase activity, following either cAMP or forskolin stimulation (Figure 4c ).
cAMP-dependent ERK phosphorylation also mediates the FSH proliferative effect
From the observation that FSH promoted proliferation of Sertoli cells via an ERK signalling cascade requiring cAMP and PKA, it could be anticipated that proliferation would also rely on cAMP. To investigate this possibility, E2F-driven luciferase activity (Figure 5a ) and S phase nuclei ( Figure 5b ) were evaluated after stimulation of cells with forskolin and cAMP. Forskolin and cAMP mimicked FSH stimulation of E2F, and cAMP increased the number of S phase nuclei, over kinetic experiments. PD98059 signi®cantly decreased the forskolin-induced proliferative eect (Figure 5c ). Therefore, in Sertoli cells isolated 5 days post-partum, cAMP-elevating agents such as FSH seem able to promote ERK-mediated proliferation.
A PTX-sensitive step is also required for FSH-induced ERK activation and proliferative response For many other GPCRs such as the b 2 -or a 1B adrenergic receptors whose binding to their cognate agonist leads to MAP kinase activation, a coupling to respectively Gi or Gq heterotrimeric proteins is a pre-requisite . We next investigated whether, in addition to coupling to Gs, coupling of the FSH-R to Gi could also potentiate ERK1,2 activation, and possibly proliferation. For this purpose, on the basis of B. pertussis toxin (PTX) sensitivity of the Ga i -mediated signalling events, primary Sertoli cells were pre-treated with PTX ( Figure 6a , lanes 4 ± 6) prior FSH (lanes 2, 5) or EGF (lanes 3, 6) stimulation, or were left untreated (lanes 1, 4). Unlike following EGF treatment, activation of ERK in response to FSH was sensitive to PTX, indicating that it could also depend on coupling of the FSH-R to Gi. We favour a coupling of the FSH-R to Ga i and not to the Ga o subtype, which is also PTX-sensitive but is not expressed in Sertoli cells (Paulssen et al., 1991) . From these results, we conclude that the FSH-R must be dually coupled to Gs and to Gi to stimulate the ERK MAP kinases. Sertoli cells were also pre-incubated (Figure 6b, lanes 3, 4) or not (lanes 1, 2) with PTX, and subsequently stimulated by forskolin (lanes 2, 4) in order to mimick the Gs component of FSH action. We observed that PTX markedly inhibited forskolin-induced ERK activation, which con®rms that in Sertoli cells, cAMP-dependent ERK activation requires both Gs-and Gi-dependent events to occur.
Coupling to Gi was also required for Sertoli cell proliferation in 5-day-old animals, since pre-incubation of cells with PTX signi®cantly decreased FSH-induced Figure 6C ) and FSH-stimulated S phase entry ( Figure 6D ). Taken together, these results demonstrate that both G s and G i heterotrimeric complexes contribute to the ERK-mediated mitogenic eect of FSH.
Opposite effect of FSH on the ERK pathway during Sertoli cell maturation
Since FSH triggers both proliferation and dierentiation of Sertoli cells in vivo, it could be expected that the 6, 9 ) stimulation, Sertoli cells were preincubated for 30 min with H89 (10 mM) (lanes 4 ± 6), or NF449 (10 mM) (lanes 7 ± 9), or were left untreated (lanes 1, 4, 7) . Immunodetection of the phosphorylated ERK1,2 in the respective lysates was performed as above. The membrane was re-probed as in Figure 1b. (c) After pre-incubation for 30 min with PD98059 as indicated, transfected Sertoli cells were either left unstimulated (control) or were stimulated with forskolin or with di(But)-cAMP for 8 h, and then were assayed for RRE-driven luciferase activity. Normalized results are expressed as RLU610 2 , and represent mean values+s.e.m.
Stage-specific regulation of ERK1,2 by FSH P Cre Â pieux et al pleiotropic biological function of the hormone could rely on progressive maturation of the signalling machinery. Hence, we next sought to investigate how the ERK pathway evolves during Sertoli cell maturation, in response to the hormone. For this purpose, ERK phosphorylation levels were compared in Sertoli cells isolated from 5-day-(see above), 12-day-and 19-day-old rats, i.e. before (12 days) and by the time (19 days) the blood-testis barrier is being completed in vivo.
ERK phosphorylation was stimulated upon FSH treatment in Sertoli cells from 12-day-old rats ( Figure  7a) . In striking contrast, in 19-day-old animal Sertoli cells, ERK phosphorylation was inhibited by FSH ( Figure 7a, lanes 1 ± 5) . Consistently, RRE-driven activity was not stimulated by FSH (Figure 7b ). In addition, forskolin was able to mimick FSH inhibitory eect on the ERK pathway (Figure 7c ), while preincubation of cells with PTX slightly added to the Stage-specific regulation of ERK1,2 by FSH P Cre Â pieux et al inhibitory eect (not shown). Therefore, at any age, cAMP promotes FSH biological activity but with divergent outcomes on the ERK pathway.
When compared at both ages, cAMP production in response to FSH (Figure 7d ) was low peri-natally, but abundant at 19 days after birth. However, at 5 days post-partum, the cAMP basal level was much higher than at 19 days.
To con®rm that the changes observed are not due to a dierential maturation of the ERK pathway components, the EGF-induced ERK1 and 2 stimulation was examined. We observed that ERK activation remained unaltered at any age (Figure 7a , lanes 6), indicating that evolution of the ERK activation level in response to FSH is strictly dependent on FSH-Rassociated signalling events. Likewise, to ascertain that Sertoli cell maturation was not altered by the culture conditions used, transferrin levels were measured at dierent ages, since transferrin is a marker progressively upregulated in the course of their dierentiation (Suire et al., 1997). As expected, transferrin, measured by competitive radio-immuno-assay, was more abundantly produced at 12 and 19 days than at 5 days postpartum (data not shown).
When compared with cells isolated from neonates, FSH still weakly stimulated E2F-driven luciferase Figure 8a ), and modestly enhanced the ratio of S phase nuclei (Figure 8b) . Strikingly, the ratio of S phase nuclei was elevated at this age, but was however only slightly enhanced by FSH stimulation. In cells isolated from 19-day-old animals, neither E2F activity nor the ratio of S phase cells was aected by FSH treatment. Kinetic measurements of E2F activity following 4 ± 16 h of FSH stimulation provided similar results (data not shown). And accordingly, cyclin D1 level was insensitive to FSH treatment (Figure 8c ). Hence, Sertoli cells isolated respectively 12 and 19 days after birth still signi®cantly proliferate in culture as revealed by¯ow cytometry analysis, but only modestly depend on FSH for their growth, in contrast with cells isolated 5 days after birth.
Discussion
The present study sought to decipher the sequence of signalling pathways induced by FSH during the course of Sertoli cell maturation. Using a primary cell culture model, we show that in cells isolated 5 days after birth, following dual coupling of its receptor to Gs and Gi, FSH stimulates a cAMP-dependent ERK activation, which supports a proliferative response. Conversely, in cells isolated 19 days post-partum, FSH negatively regulates the ERK pathway. Furthermore, our results suggest that cAMP can be developmentally involved in opposite functions of a hormonal stimulus since, upon FSH stimulation, cAMP production in neonate is weak and is elevated at 19 days postpartum. Consistently, forskolin mimicked FSH-induced ERK activation at 5 days post-partum and ERK inhibition at 19 days post-partum, which further substantiates a role for cAMP in this maturation process. The observation that the basal level of cAMP is high at 5 days post-partum and weak at 19 days post-partum could re¯ect developmental maturation of the phosphodiesterase (PDE) panoply in Sertoli cells. At 5 days post-partum, PDE expression level is weak in Sertoli cells (Monn et al., 1972) , which could Figure 1b explain the high basal cAMP level measured. Interestingly, MAP kinases can regulate intracellular cAMP levels by phosphorylating phosphodiesterases such as PDE4 isoforms (MacKenzie et al., 2000) . In our study, cAMP could also mimick the FSH eect on proliferation in neonate. Of note, it was reported that low cAMP levels induced proliferation of granulosa cells upon FSH stimulation while high cAMP levels trigger their dierentiation upon LH (luteinizing hormone) stimulation (Robker and Richards, 1998).
As previously documented for the b2-adrenergic receptor in HEK293 cells , our results indicate that the FSH-R dually couples to both Gs and Gi heterotrimeric proteins to achieve ERK activation. Most likely, Gas-initiated events only partially account for direct activation of the ERK cascade, since it is shown here that adenylyl cyclase stimulation by forskolin cannot bypass the inhibitory action of PTX, thereby suggesting that in Sertoli cells, cAMP-mediated ERK activation mainly relies on Gi recruitment. The property shared by RGS proteins (Regulator of G protein Signalling) to serve as GAP selectively de-activating various Ga isoforms, but not the Gas subtype (Dolhman and Thorner, 1997) , was utilized to con®rm the involvement of Ga i in the FSHmediated signalling: introduction of RGS3 in Sertoli cells isolated at 12 days after birth decreased the RREdependent luciferase activity, and increased activity of a cAMP-responsive promoter (our unpublished data). Whether the FSH-R can couple stepwise or simultaneously to both Gas and Gai deserves to be addressed. Unfortunately, the low number of FSH-R in Sertoli cells (about 1000 per cell) unabled our attempts to investigate the sequence of the FSH-R coupling to the dierent G protein subtypes by GTP-loading experiments (our unpublished observation). This is the ®rst report suggesting that Src could be involved in FSH-mediated signalling, based on the inhibitory eect of the PP2 Src-speci®c inhibitor. Src activation is a signalling event that can be common to many tyrosine-kinase receptors, non-tyrosine-kinase receptors and PTX-sensitive GPCRs. For the angiotensin II receptor in smooth muscle cells (Schieer et al., 1996) or the b 2 -adrenergic receptor in HEK293 cells (Luttrell et al., 1999) , recruitment of Src seems to be mediated either through Gbg , or through b-arrestin (Luttrell et al., 1999) . As yet, our results cannot help to discriminate between these two possibilities.
We demonstrate here that cyclin D1 expression is upregulated by FSH, in a MEK1-dependent manner. In granulosa cells, cyclin D2, but not cyclin D1, is an early FSH-responsive gene (Sicinski et al., 1996) , but the signalling pathways which mediate FSH-dependent cyclin D2 expression have not been described yet. Besides, in dierent cell lines, cyclin D1 is potentially targeted by the ERK pathway (Lavoie et al., 1996) via phosphorylation of the ETS-2 (Albanese et al., 1995) , CREB and LEF (Tetsu and McCormick, 1999) transcription factors but the extra-cellular stimuli which induce cyclin D1 expression have been poorly de®ned.
Our ®nding is of interest because it identi®es cyclin D1 as a new FSH-target gene, hence providing a molecular basis for FSH proliferative eect in male. At 12 days after birth, the ERK cascade is still inducible but the FSH-dependent Sertoli cell proliferation rate decreases. Interestingly, in vivo, the onset of the formation of the blood-testis barrier in male rat starts 12 days after birth, when tight junctions start to form between cells, supposedly hindering further proliferation. Therefore, the evolution of two interacting signalling pathways, ERK1,2-and cAMP-mediated, could be relevant for the morphogenetic events related to the establishment of the blood-testis barrier. At 19 days after birth, exposure to the hormone actively inhibits the ERK pathway, and cyclin D1 becomes insensitive to the FSH input. Interestingly, in other cell models, cyclin D1 expression (Lavoie et al., 1996) is a target of cAMPmediated inhibition of cell cycle entry (L'Allemain et al., 1997) . This cyclin was initially identi®ed as the bcl-1 oncogene, which contributes signi®cantly to some human malignancies when stabilized or over-expressed (Hall and Peters, 1996) . Whether or not cyclin D1 dysregulation is involved in the establishment of some FSH-insensitive gonadal tumour types which could result from alteration of the hormone-induced signalling (Fuller et al., 1998) deserves to be addressed.
FSH-R-mediated signalling has been mainly investigated in cell lines or in cells with enforced expression of a receptor. (e.g. Lazari et al., 1999; Troispoux et al., 1999) . In these cell models, the stoichiometry of the dierent interacting eectors, which has proven to be an important requirement for proper GPCR signalling, could be dramatically altered (Stanislaus et al., 1998) . This observation emphasizes the usefulness of primary culture cell models to depict signalling events physiologically relevant.
In conclusion, this study illustrates how a single hormone can trigger both activation and inhibition of the ERK MAP kinases in a stage-speci®c manner that may switch the biological response to the hormone from proliferation to dierentiation.
Materials and methods
Pharmacological reagents
Porcine FSH was puri®ed by Dr Yves Combarnous in our laboratory and by Dr Jean Closset (UniversiteÂ de LieÁ ge, Belgium). Forskolin, di-butyryl-cAMP, Bordetella pertussis toxin (PTX) were purchased from Sigma Chemical Co. ParkDavis (PD) 98059 and U0126 were purchased from New England Biolabs Inc., Epidermal Growth Factor (EGF) and H89 were purchased from ICN Pharmaceuticals Inc., NF449 and PP2 were purchased from Calbiochem-Novabiochem Corp.
Primary Sertoli cell culture
Sertoli cells were isolated from testes of 5-, 12-and 19-dayold Wistar rats (Ia Credo, Lyon, and Janvier, St-Isle, France) and grown in DMEM (Life Technologies Inc.)
Oncogene Stage-specific regulation of ERK1,2 by FSH P Cre Â pieux et al complemented with Streptomycin, Glutamine, Retinol, Fungizone, Vitamine E and transferrin as reported previously (Guillou et al., 1986) . In average, our Sertoli cell cultures were 100% pure at 5 days post-partum, 90% pure at 12 days, and at 19 days, as previously quanti®ed (Troispoux et al., 1998) . Respective assays were performed the day following their initial seeding.
Nucleus purification and flow cytometry cell cycle analysis
One million Sertoli cells was stimulated with FSH (100 ng/ml) for 8 h, rinsed in phosphate-buered saline and then nuclei were isolated. Brie¯y, cells were gently re-suspended and disrupted for 10 min on ice in a lysis buer containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.2 mM EGTA, 0.5 mM PMSF, 5 mg/ml spermidin, 5 mg/ml spermin and 0.1% Nonidet P-40. After centrifugation at 13 400 g, 48C, nuclei were gently re-suspended in lysis buer/ RNase A and incubated for 1 h at 378C, then stored at 48C until used. After propidium iodine staining (50 mg/ml, 30 min at 48C, Molecular Probes, Eugene, OR, USA), cell cycle was analysed with a¯ow cytometer Star Plus (Becton-Dickinson, San JoseÂ , CA, USA). The three main phases of the cell cycle (2C, 4C and S phase) were delineated using the CellFit TM software (Becton-Dickinson, San JoseÂ , CA, USA).
Immunoblot analysis and antibodies
Forty micrograms of total cell lysates were resolved by SDS ± PAGE, electrophoretically transferred to PVDF membrane (NEN Life Science Products) and probed with anti-phosphop44 ERK1 /p42 ERK2 monoclonal antibodies (New England Biolabs Inc.), with anti-cyclin D1 monoclonal antibody (Santa Cruz) or with rabbit anti-cyclin D1 polyclonal antibody (a generous gift from Dr Pierre Savatier, Lyon, France). As indicated in the text, blotting membranes were re-probed with a goat anti-p44 ERK1 or with a rabbit anti-p42 ERK2 /p44 ERK1 polyclonal antibody (Santa Cruz) to normalize gel loading. Horseradish peroxydase-coupled anti-mouse, anti-rabbit or anti-goat antibodies (Sano®/Pasteur) were used to detect antigen-antibody interactions by enhanced chemioluminescence (NEN Life Science Products). For immunostaining, ā uorescein isothiocyanate (FITC)-coupled anti-mouse IgG secondary antibody was used (Jackson Immunoresearch Laboratories).
Immunostaining
After dissection of 5-day-old rats, primary Sertoli cells isolated were seeded on glass 8-well chamber slides (Nalge Nunc Int., Naperville, USA) (250 000 cells per well) overnight. After stimulation with FSH (100 ng/ml) for 1 h, cells were ®xed with 4% paraformaldehyde for 15 min at 48C and rinsed with Tris 0.25 M pH 7.5/ NaCl 0.5 M (TBS) for 5 min. Then, they were incubated for 5 min. with 3% H 2 O 2 / 10% MetOH, and rinsed three times for 10 min each with TBS. After permeabilization for 15 min in TBS/0.2% Triton, cells were rinsed three times for 5 min each with TBS and then incubated with anti-phospho ERK antibody (dilution 1 : 100) for 72 h at 48C. After three rinses in TBS, chamber slides were incubated with an FITC-labelled anti-mouse IgG secondary antibody for 48 h at 48C (dilution 1 : 200). After three rinses in TBS, slides were mounted in 4,6-diamino-2-phenylindole (DAPI)-containing VectaShield (Vector Laboratories, CA, USA) for¯uorescence microscopy examination.
Quanti®cation was performed with a Princeton measurement software.
Plasmids
The Ras-Responsive Element-driven ®re¯y luciferase reporter plasmid (RRE-luc) contains three tandem repeats of a polyoma virus-derived sequence with Ets-and AP1-binding sites linked to the thymidine kinase promoter. E2F-driven ®re¯y luciferase reporter plasmid (E2F-luc) contains three E2F-and one Sp1-binding sites linked to the thymidine kinase promoter, and was provided by Dr A. Harel-Bellan, Villejuif, France.
Luciferase reporter gene activity
As previously described (Guillou et al., 1991), 10 6 Sertoli cells per well were co-transfected in 24-well culture plates by the calcium phosphate precipitation method with 100 ng of each reporter plasmid (see above) and 50 ng of renilla luciferase plasmid to normalize transfection eciency. Twenty-four hours after transfection, cells were added with fresh complemented medium before stimulation with FSH (100 ng/ml) for 6 h, then rinsed in phosphate-buered saline, and lysed according to the manufacturer's instructions (Dual luciferase assay, Promega). Both ®re¯y and renilla luciferase activities were quanti®ed on a Turner TD20/20 luminometer. Each assay was performed in triplicate, with at least three separate Sertoli cell preparations.
cAMP radio-immuno assay
Cell supernatants were dessicated, re-suspended in 100 ml phosphate-buered saline, and incubated overnight each with 3610 73 mCi of I 125 -cAMP according to the manufacturer's instructions (Immunotech Inc., Marseille, France).
Statistics
Unless otherwise stated, luciferase reporter gene activity,¯ow cytometry data and cAMP measurements carried out in triplicates were expressed as mean values+s.e.m. of at least three independent experiments. Data were analysed by Student's t-test. Values with P50.05 were considered to be statistically signi®cant. *: P50.05; **: P50.01; ***: P50.001.
